Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Inflammatory Bowel Diseases
|
November 23, 2006
Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral)
Audrey Weber, Francine Fein, Stéphane Koch, et al.
BMC Cancer
|
June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
Aziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
Plos One
|
May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
Amélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 20, 2018
High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease
Lucine Vuitton, Elise Jacquin, Anne-Laure Parmentier, et al.
Journal of the National Cancer Institute
|
April 7, 2017
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
Angélique Vienot, Guillaume Beinse, Christophe Louvet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2019
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study
Thomas Walter, Come Lepage, Romain Coriat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Inflammatory Bowel Diseases
|
November 23, 2006
Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral)
Audrey Weber, Francine Fein, Stéphane Koch, et al.
BMC Cancer
|
June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
Aziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
Plos One
|
May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial
Amélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 20, 2018
High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease
Lucine Vuitton, Elise Jacquin, Anne-Laure Parmentier, et al.
Journal of the National Cancer Institute
|
April 7, 2017
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
Angélique Vienot, Guillaume Beinse, Christophe Louvet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2019
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study
Thomas Walter, Come Lepage, Romain Coriat, et al.
Page
of 1